Dataset Information

Synthesis, biological evaluation and molecular modeling studies on novel quinonoid inhibitors of CDC25 phosphatases.

ABSTRACT: The cell division cycle 25 phosphatases (CDC25A, B, and C; E.C. 3.1.3.48) are key regulator of the cell cycle in human cells. Their aberrant expression has been associated with the insurgence and development of various types of cancer, and with a poor clinical prognosis. Therefore, CDC25 phosphatases are a valuable target for the development of small molecule inhibitors of therapeutic relevance. Here, we used an integrated strategy mixing organic chemistry with biological investigation and molecular modeling to study novel quinonoid derivatives as CDC25 inhibitors. The most promising molecules proved to inhibit CDC25 isoforms at single digit micromolar concentration, becoming valuable tools in chemical biology investigations and profitable leads for further optimization. [Formula: see text].

SUBMITTER: Evain-Bana E

PROVIDER: S-EPMC6010111 | biostudies-literature | 2017 Dec

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Synthesis, biological evaluation and molecular modeling studies on novel quinonoid inhibitors of CDC25 phosphatases.

Evain-Bana Emilie E Schiavo Lucie L Bour Christophe C Lanfranchi Don Antoine DA Berardozzi Simone S Ghirga Francesca F Bagrel Denyse D Botta Bruno B Hanquet Gilles G Mori Mattia M

Journal of enzyme inhibition and medicinal chemistry 20161023 1

The cell division cycle 25 phosphatases (CDC25A, B, and C; E.C. 3.1.3.48) are key regulator of the cell cycle in human cells. Their aberrant expression has been associated with the insurgence and development of various types of cancer, and with a poor clinical prognosis. Therefore, CDC25 phosphatases are a valuable target for the development of small molecule inhibitors of therapeutic relevance. Here, we used an integrated strategy mixing organic chemistry with biological investigation and molec ...[more]

PMID: 27774816

Dataset Information

Synthesis, biological evaluation and molecular modeling studies on novel quinonoid inhibitors of CDC25 phosphatases.

Publications

Synthesis, biological evaluation and molecular modeling studies on novel quinonoid inhibitors of CDC25 phosphatases.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets

Similar Datasets

Synthesis, molecular modeling, and biological evaluation of novel RAD51 inhibitors.
| S-EPMC4433875 | biostudies-literature

Design, Synthesis, Molecular Modeling, and Biological Evaluation of Novel Amine-based Histone Deacetylase Inhibitors.
| S-EPMC5881582 | biostudies-literature

Synthesis, Biological Evaluation, and Molecular Modeling Studies of New Thiadiazole Derivatives as Potent P2X7 Receptor Inhibitors.
| S-EPMC6511888 | biostudies-literature

Development of multitarget inhibitors for the treatment of pain: Design, synthesis, biological evaluation and molecular modeling studies.
| S-EPMC7723751 | biostudies-literature

Synthesis, molecular modeling and biological evaluation of aza-flavanones as ?-glucosidase inhibitors.
| S-EPMC6072087 | biostudies-literature

7-Methoxytacrine-adamantylamine heterodimers as cholinesterase inhibitors in Alzheimer's disease treatment--synthesis, biological evaluation and molecular modeling studies.
| S-EPMC6270602 | biostudies-literature

Synthesis, Biological Evaluation, and Molecular Docking Studies of Novel Isatin-Thiazole Derivatives as α-Glucosidase Inhibitors.
| S-EPMC6154535 | biostudies-literature

Novel Insights on Human Carbonic Anhydrase Inhibitors Based on Coumalic Acid: Design, Synthesis, Molecular Modeling Investigation, and Biological Studies
| S-EPMC9324074 | biostudies-literature

Synthesis, Biological Evaluation, and Molecular Modeling Studies of Chiral Chloroquine Analogues as Antimalarial Agents.
| S-EPMC6256754 | biostudies-literature

Novel phthalimide based analogues: design, synthesis, biological evaluation, and molecular docking studies.
| S-EPMC6691772 | biostudies-literature